More on Alexza Pharma Q2 results


Alexza Pharmaceuticals (ALXA -21.8%) Q2 results: Revenues: $1.5M (-96.6%); Operating Expenses: $12.8M (+2.1%); Operating Loss: ($11.3M) (-136.5%); Net Loss: ($6.0M) (-646.2%); Loss Per Share: ($0.34) (-580.0%); Quick Assets: $43.6M (+68.3%).

No guidance given.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs